Steris (NYSE:STE) announced today that it completed its acquisition of surgical instrumentation assets from BD . The companies announced in June that they agreed on a deal for the assets worth $540 million. BD’s divestiture includes V. Mueller, Snowden-Pencer and Genesis branded products. BD reports its surgical instrumentation platform as part of its Surgery unit […]
Steris
Steris reports strong Q1 on big gains in healthcare
Steris today reported first-quarter results that exceeded Wall Street’s expectations while upping guidance for the year ahead due to a recently announced acquisition. The Dublin, Ireland-based provider of sterilization services and other infection prevention tech posted profits of $123.6 million in the quarter ended June 30, 2023. That amounts to $1.25 per share on sales […]
BD sells surgical instrumentation assets to Steris for $540M
BD announced today that it signed a definitive agreement to sell its surgical instrumentation platform to Steris (NYSE:STE) for $540 million. The divestiture includes V. Mueller, Snowden-Pencer and Genesis branded products. BD reports its surgical instrumentation platform as part of its Surgery unit within its Interventional segment. In the deal, Steris also gets three manufacturing […]
Steris beats the Street on Q4 earnings and increases guidance
Steris (NYSE:STE) today reported fourth-quarter results that exceeded Wall Street’s expectations while upping guidance for the year ahead. Shares of STE climbed 4% t0 $197 apiece in after-hours trading. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was flat on the day. The Dublin, Ireland-based provider of sterilization services and […]
Steris stock dives on Q3 misses, slashed 2023 guidance
Steris (NYSE:STE) shares took a hit today — a day after reporting third-quarter results that missed the consensus forecast on Wall Street. Shares of STE dipped more than 9% at $195.42 apiece by midday trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up more than 10%. The […]
Steris sticks by EPS guidance amid additional currency headwinds
Steris (NYSE: STE) reported mixed third-quarter results, but it held the line on EPS guidance amid additional foreign currency headwinds. The provider of sterilization services and other infection prevention tech lost $315.2 million, or $3.15 per share, off $1.20 billion in revenue for the quarter ended Sept. 30, 2022. Steris swung to a loss versus […]
Steris shares drop on Q1 swing-and-miss, lowered outlook
Steris (NYSE:STE) posted first-quarter results today that fell short of the consensus forecast on Wall Street and reduced its outlook for the rest of the year, despite swinging to a profit from a loss a year ago. The infection prevention technology company — headquartered in Dublin, Ireland, and run operationally out of Mentor, Ohio — […]